OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Van Lanschot Kempen NV/  NL0000302636  /

Cboe Europe DXE
5/31/2024  5:29:46 PM Chg. +0.10 Volume Bid5:30:00 PM Ask5:30:00 PM Market Capitalization Dividend Y. P/E Ratio
37.65EUR +0.27% 12,008
Turnover: 113,822.60		 -Bid Size: - -Ask Size: - 1.6 bill.EUR 5.32% 13.33
GlobeNewswire 5/30 Merus Announces Pricing of Upsized Public Offering of Common Shares
GlobeNewswire 5/28 Merus N.V. Announces Proposed Public Offering of Common Shares
GlobeNewswire 4/5 ORYZON to Provide Corporate Progress Updates at Several Events in April
GlobeNewswire 4/4 Oculis to Participate at Upcoming April Investor Conferences
GlobeNewswire 4/3 Pharming Group to participate in April investor conferences
GlobeNewswire 3/18 Transgene Announces Upcoming Investor Meetings
GlobeNewswire 3/4 Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire 2/29 MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire 2/8 Autolus Announces Pricing of Underwritten Offering
GlobeNewswire 1/31 Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
GlobeNewswire 12/22/2023 Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire 10/10/2023 Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
euro adhoc 9/9/2021 EANS-News: Atrium European Real Estate Limited / Publication of Scrip Dividend Circular Q3 2021 CNE
euro adhoc 6/9/2021 EANS-News: Atrium European Real Estate Limited / Publication of Scrip Dividend Circular Q2 2021 CNE
GlobeNewswire 2/9/2021 SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire 2/9/2021 SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT
GlobeNewswire 7/7/2020 Mid-Stabilisation Period Announcement
GlobeNewswire 6/26/2020 Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire 6/24/2020 Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire 6/19/2020 Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire 6/18/2020 Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire 6/17/2020 Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
GlobeNewswire 6/3/2020 Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussel...
GlobeNewswire 1/22/2020 Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement
GlobeNewswire 1/22/2020 SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT